The partial reversal by SC79 further supports that these antitumor effects are mediated through inhibition of the EGFR/Akt/mTOR pathway, suggesting that amlodipine holds significant therapeutic potential against glioblastoma via targeting GSCs. This evidence concerns the gene EGFR and glioblastoma.